3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
4
Glioblastoma
3
Head and Neck Neoplasms
2
Glioma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Papillary renal cell carcinoma, sporadic
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Osteoradionecrosis
1
Neurotoxicity Syndromes
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hereditary leiomyomatosis and renal cell cancer
1
Hematopoietic and Lymphoid System Neoplasm
1
Healthy Volunteers
1
Gliosarcoma
1
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
3
Pancreaticoduodenectomy
2
Oxaliplatin
2
Irinotecan
2
titanium silicide
1
tislelizumab
1
sonidegib
1
paricalcitol
1
mitazalimab
1
lenvatinib
1
ivosidenib
1
irinotecan sucrosofate
1
glucoraphanin
1
devimistat
1
Transurethral Resection of Prostate
1
Tissue Banks
1
Taxes
1
Specimen Handling
1
Saline Solution
1
S 1 (combination)
1
Ropivacaine
1
Robotic Surgical Procedures
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
PEGPH20
1
Neoadjuvant Therapy
1
Losartan
1
Leucovorin
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pancreatic Ductal Adenocarcinoma
×
Contrast Media
×
Clear all
NCT07324096
2026-03-27
AI-PACED
Mayo Clinic
Phase NA
Recruiting
100 enrolled